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Abstract
Background: Inhibition of apoptosis is one of the mechanisms selected by numerous intracellular pathogenic bacteria to
control their host cell. Brucellae, which are the causative agent of a worldwide zoonosis, prevent apoptosis of infected cells,
probably to support survival of their replication niche.
Methodology/Principal Findings: In order to identify Brucella melitensis anti-apoptotic effector candidates, we performed a
genome-wide functional screening in yeast. The B. melitensis ORFeome was screened to identify inhibitors of Bax-induced
cell death in S. cerevisiae. B. melitensis porin Omp2b, here shown to be essential, prevents Bax lethal effect in yeast, unlike its
close paralog Omp2a. Our results based on Omp2b size variants characterization suggest that signal peptide processing is
required for Omp2b effect in yeast.
Conclusion/Significance: We report here the first application to a bacterial genome-wide library of coding sequences of this
‘‘yeast-rescue’’ screening strategy, previously used to highlight several new apoptosis regulators. Our work provides B.
melitensis proteins that are candidates for an anti-apoptotic function, and can be tested in mammalian cells in the future.
Hypotheses on possible molecular mechanisms of Bax inhibition by the B. melitensis porin Omp2b are discussed.
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Introduction
During the complex evolution of intracellular pathogenic
bacteria with their host, mechanisms have been selected that
allow bacteria to modulate host cell functions to their advantage.
Examples of hijacking of the host cell cytoskeleton [1], signaling
[2] and vesicular trafficking [3] by bacterial pathogens are
numerous. Pirated processes include apoptosis, a form of pro
grammed cell death that can serve as a defense mechanism to avoid
pathogen propagation [4]. Inhibition of apoptosis, which has been
reported for a variety of intracellular bacteria, probably supports
survival of their replication niche [5].
Monocytes or macrophages infected by the facultative intracel-
lular pathogenic bacteria of the Brucella genus, which are
responsible for a worldwide zoonosis [6], are protected from
apoptosis [7]. Furthermore, modulation of the expression of genes
encoding apoptotic proteins in infected cells has been described
[7,8]. The gene encoding an anti-apoptotic protein of the Bcl-2
family, A1/Bfl1, is overexpressed in Brucella-infected monocytes
compared with non-infected cells [7]. However, the bacterial
molecular mechanisms leading to apoptosis inhibition, probably
involving production of effector protein(s), are still unknown.
Interestingly, the genetically tractable and easy to handle yeast
Saccharomyces cerevisiae is known to be an attractive model for the
functional study of proteins involved in apoptosis, such as the Bcl-2
family members [9]. The budding yeast lacks homologs of the
mammalian core apoptotic proteins, providing a simplified model
for individual characterization of apoptosis regulators without the
bias due to the rest of the network. Several proteins involved in
apoptosis have an effect in yeast that is relevant to their
physiological function [9]. For instance, the ectopic production
of the mammalian pro-apoptotic Bax in yeast induces a form of
cell death, which requires Bax insertion into the outer membrane
of mitochondria (OMM). In mammalian cells, Bax translocation
to mitochondria occurs upon pro-apoptotic signaling and leads to
mitochondrial outer membrane permeabilization (MOMP) [10], a
required event for subsequent apoptosis. Pleiotropic effects are
observed upon Bax production in yeast, including several features
shared with mammalian apoptosis such as MOMP, cytochrome c
release and the maintenance of plasma membrane integrity [11].
These characteristics, in addition to the fact that Bax-induced cell
death in yeast can be reverted by known anti-apoptotic proteins,
such as Bcl-2 and Bcl-XL [12], strongly support a common
ancestral pathway to controlled cell death. Hence, S. cerevisiae has
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inhibitors. A screening strategy to identify inhibitors of Bax-
induced cell death in yeast [13] has been applied previously to
identify new human anti-apoptotic proteins [14,15,16] and plant
inhibitors of cell death [17,18]. In addition, assay of Bax-induced
cell death inhibition in yeast has contributed to the characteriza-
tion of human [16] and plant [19] proteins known to be involved
in inhibition of apoptotic or hypersensitive response (HR)
programmed cell deaths, respectively, as well as bacterial proteins
playing a role in host HR cell death inhibition [20] or described as
secreted anti-apoptotic effector [21].
Several bacterial effectors that target eukaryotic signaling
pathways have been highlighted using diverse functional screening
approaches in yeast [22]. The availability of the Brucella melitensis
ORFeome prompted us to perform a genome-wide functional
yeast-based screening to identify B. melitensis anti-apoptotic effector
candidates. Here we report the results of a screening for Bax
suppressors in yeast, applied for the first time to a bacterial
genome-wide library of coding sequences.
Results and Discussion
In order to identify Brucella melitensis proteins that inhibit Bax-
induced cell death in yeast, we took advantage of the B. melitensis
ORFeome [23], which is a standardized library of predicted
coding sequences (ORFs), to construct a yeast library in which
each clone contains murine bax and one of the ,3,200 B. melitensis
ORFs. bax and the B. melitensis ORFs expression are controlled by
the galactose-inducible, glucose-repressible pGAL10 and pGAL1
promoters, respectively. This ‘‘bax + ORFeome’’ library was
screened for colonies with a plasmid-borne growth phenotype
under bax and ORFs expression condition (see Text S1 in the
Supporting information for library construction and further
screening details). 116 different ORFs were identified from the
136 colonies obtained at this step of the screen. In order to get rid
of false positives that are expected to be selected in this type of
large-scale screen of a genome-wide pool of ORFs, the next step of
the screening procedure consisted in individually testing all
candidates in conventional growth assays [13]. Thus, the 116
pYES-DEST52 ORFs were individually recloned from the
original entry vectors of the ORFeome before transformation of
a yeast strain containing bax (QX95001, see Table 1 for all strains
used in this study). Each of the 116 strains was submitted to growth
assays (streaks and drops of serial dilutions on plate) under
induction or repression conditions of bax and ORFs expression.
The positive control of growth was GL0001 yeast strain containing
bax and bclXL. Indeed, the anti-apoptotic Bcl-XL protein has been
shown to inhibit Bax-induced cell death in yeast [12] as in
mammalian cells by preventing Bax insertion into mitochondria
and its acquisition of a final conformation able to induce MOMP
[24]. The negative control was the GL0016 yeast strain containing
bax and the empty pYES-DEST52 destination vector. Out of the
Table 1. Yeast and bacterial strains used in this study.
Name Strain Use and relevant features Medium
Reference and
sources
DH10B E. coli; F
2 mcrA D(mrr-hsdRMS-mcrBC)
phi80lacZDM15 lacX74 recA1 endA1
araD139 D(ara leu)7697 galU galK
lambda
2 rps (Str
r) nupG
cloning strain LB Gibco BRL
S17-1 E. coli; recA thi pro hsdR [res– mod+]
[RP4::2-Tc::Mu-Km::Tn7]
lambda-pir phage lysogen
plasmid mobilization in B. melitensis LB [41]
BF264-15 Dau S. cerevisiae (MATalpha ade1 his2 leu2-3,
112 trp1-1a ura3)
yeast strain used in this study for transformation with
plasmids harboring LEU2 or URA3
Sc [42] [43]; kindly
provided
by M. Grant, Wye
College, UK
QX95001 BF264-15 Dau + pYEp51-bax [44] bax controlled by pGAL10 (pGAL10-bax) Sc-Leu [13]
GL0001 QX95001 + pYES-DEST52-bclXL pGAL10-bax + pGAL1-bclXL-V5-His6 Sc-Leu-Ura This study
GL0002 BF264-15 Dau + pYES-DEST52-BMEI1305 pGAL1-omp2b-V5-His6 Sc-Ura This study
GL0003 BF264-15 Dau + pYES-DEST52-BMEI0660 pGAL1-fecE-V5-His6 Sc-Ura This study
GL0004 QX95001 + pYES-DEST52-BMEI1305 pGAL10-bax + pGAL1-omp2b-V5-His6 Sc-Leu-Ura This study
GL0005 QX95001 + pYES-DEST52-BMEI0660 pGAL10-bax + pGAL1-fecE-V5-His6 Sc-Leu-Ura This study
GL0007 QX95001 + pYES-DEST52-BMEI1306 pGAL10-bax + pGAL1-omp2a-V5-His6 Sc-Leu-Ura This study
GL0008 QX95001 + pYES-DEST52-BMEI1249 pGAL10-bax + pGAL1-omp25-V5-His6 Sc-Leu-Ura This study
GL0010 BF264-15 Dau + pYES-DEST52-t-omp2b pGAL1-t-omp2b-V5-His6 Sc-Ura This study
GL0011 QX95001 + pYES-DEST52-t-omp2b pGAL10-bax + pGAL1-t-omp2b-V5-His6 Sc-Leu-Ura This study
GL0012 BF264-15 Dau + pYES-DEST52- short-omp2b pGAL1-short-omp2b-V5-His6 Sc-Ura This study
GL0013 QX95001 + pYES-DEST52-short-omp2b pGAL10-bax + pGAL1-short-omp2b-V5-His6 Sc-Leu-Ura This study
GL0014 BF264-15 Dau + pYES-DEST52-BMEI1306 pGAL1-omp2a-V5-His6 Sc-Ura This study
GL0015 BF264-15 Dau + pYES-DEST52-BMEI1249 pGAL1-omp25-V5-His6 Sc-Ura This study
GL0016 QX95001 + pYES-DEST52 pGAL10-bax + empty destination vector Sc-Leu-Ura This study
GL0017 QX95001 + pYES-DEST52-long-omp2a pGAL10-bax + pGAL1-long-omp2a-V5-His6 Sc-Leu-Ura This study
GL0018 BF264-15 Dau + pYES-DEST52-long-omp2a pGAL1-long-omp2a-V5-His6 Sc-Ura This study
doi:10.1371/journal.pone.0013274.t001
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B. melitensis ORF BMEI1305 or BMEI0660, reproducibly grew as
well as the control GL0001 strain (Figure 1A). These ORFs
encode Omp2b and FecE proteins, respectively. FecE is predicted
to be a cytoplasmic ATP-binding protein associated with other
components of an iron (III) ABC transporter. Omp2b is described
as a porin [25]. The production of both Omp2b and FecE in yeast
(GL0002 and GL0003 strains, respectively) was checked by
Western blot analysis (Figure 1B). The growth phenotype
conferred by Omp2b or FecE is not linked to an absence or
decrease of Bax production as Bax was detected in yeast expressing
bax and omp2b or fecE (GL0004 and GL0005, respectively) like in
GL0001 strain (Figure 1C). Thus, our screen identified two B.
melitensis proteins, Omp2b and FecE, of which the expression in
yeast prevents cell death induced by the mammalian pro-apoptotic
protein Bax. FecE mechanism of action regarding the inhibition of
Bax-induced yeast lethality remains to be investigated but may be
related to its ATPase activity, considering the various implications
of ATPases in intracellular signaling pathways. However we
cannot exclude that FecE effect in yeast is independent of this
predicted function. Nevertheless, the ability of FecE to act as an
anti-apoptotic effector should be tested in the future in other
models than the yeast-based system used here as a screening tool.
Because bacterial porins were already reported to be involved in
apoptosis modulation [26,27,28], this study focuses on the second
candidate, Omp2b. Outer membrane proteins (OMPs) harbor a
N-terminal signal peptide (SP) for the recognition and cleavage of
the unfolded proteins by the Sec system before their secretion in
the periplasm and the folding and insertion of the mature proteins
into the bacterial outer membrane [29]. In the B. melitensis
ORFeome, the deduced sequence from omp2b ORF contains a
long predicted SP (PSP). A truncated form of Omp2b lacking the
entire PSP (t-Omp2b) only poorly inhibits Bax effects in yeast
(GL0011) when compared with negative and positive control
strains GL0007 and GL0004 (Figure 2A and 2B). This lower
protection against Bax lethal effects is not related to a toxicity
induced by t-Omp2b since a strain lacking bax and producing t-
Omp2b (GL0010) grows similarly as the GL0004 strain that
produces Omp2b (data not shown). In addition, a variant of
Omp2b harboring a N-terminally shortened SP (short-Omp2b)
completely looses the anti-Bax effect (GL0013), indicating that the
production of Omp2b with its complete PSP is required for a
strong Bax inhibition in yeast (Figure 2A and 2B).
Interestingly, Omp2b and t-Omp2b are detected on Western
blot at a similar apparent molecular weight, which is lower than
the one observed for short-Omp2b (Figure 2C), suggesting that
Omp2b PSP is cleaved in yeast, unlike the shortened PSP of the
short-Omp2b form. Notably, t-Omp2b was reproducibly detected
in a much lesser quantity in Western blot when compared with
Omp2b (Figure 2C), which could account for its weaker ‘‘anti-
Bax’’ effect. This might suggest that the PSP, and/or the PSP
cleavage event, are required for Omp2b production or stability
leading to protein levels that are sufficient to remarkably inhibit
Bax lethal effects. Altogether, our results support the requirement
of PSP cleavage for Omp2b anti-Bax effect in yeast. The
processing of Omp2b PSP in yeast is not surprising considering
Figure 1. Omp2b and FecE allow yeast growth under bax expression conditions. A. Drops of serial dilutions of cultures in stationary phase,
on media allowing repression or induction of bax and ORF expression. Dilution factors are indicated. Pictures were taken after 4 days of growth at
30uC. GL0001 (bclXL) and GL0016 (/): positive and negative controls for growth, respectively. Growing strains were submitted to PCR and sequencing,
identifying B. melitensis omp2b (GL0004) and fecE (GL0005). B. Western blot detection of Omp2b and FecE (fused to a C-terminus His6 tag when
expressed from pYES-DEST52 vector used for screening), in total protein extracts from GL0002 (omp2b) and GL0003 (fecE) yeast strains cultured under
conditions of bax and ORF expression induction. C. Western blot detection of Bax (21 kDa) in total protein extracts from GL0004 (omp2b), GL0005
(fecE) and GL0001 (bclXL) yeast strains cultured under conditions of bax and ORF expression repression (left part) or induction (right part).
Phosphoglycerate kinase (PGK) detection: loading control.
doi:10.1371/journal.pone.0013274.g001
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eukaryotic cells [30,31,32]. We hypothesize that the processed
mature form of Omp2b could adopt a fold allowing its particular
subcellular localization or interaction with physical partners,
which might lead to the inhibition of Bax-induced effects. This
is supported by the Western blot detection of a high molecular
weight form of Omp2b in a GL0002 strain protein extract, in
semi-denaturing conditions, at a size expected for the trimeric
assembly of the porin (data not shown).
Only two ORFs encode porin homologs (Omp2a and Omp2b)
in the B. melitensis genome. Omp2b is encoded on the opposite
strand and next to BMEI1306 ORF encoding Omp2a. Omp2b
shares 83% identity with Omp2a. To assess the specificity of
Omp2b in the inhibition of Bax-induced cell death in yeast, we
tested the effect of Omp2a, but also of Omp25, a major B. melitensis
outer membrane proteins (OMP), on the growth of yeast
expressing bax (GL0007 and GL0008, respectively). None of them
(3 independent clones tested by strain) was able to rescue yeast
from Bax-induced cell death (Figure 3). The production of those
proteins in GL0007 and GL0008 has been verified by Western
blot (Figure S1 of Supporting information), suggesting that their
inability to rescue yeast from Bax-induced cell death is not due to
the absence of the OMPs. Their expression had no effect on the
growth of the wild type yeast strain BF264-15 Dau (GL0014 and
GL0015, data not shown), arguing against their hypothetical
toxicity for this strain. Thus, the ‘‘anti-Bax’’ effect of Omp2b is
specific to this OMP, since it is not even observed for Omp2a
although both porins share high sequence similarity. Omp2a
predicted signal peptide is identical to the shortened PSP of short-
Omp2b. To determine if the functional difference between
Omp2a and Omp2b can be explained by the difference in signal
peptides, we constructed a version of Omp2a, in which the
predicted signal peptide sequence has been replaced by the full
Omp2b PSP (long-Omp2a). When expressed in yeast (GL0017),
long-Omp2a was not able to prevent Bax-induced cell death,
suggesting that although Omp2b PSP is required for Omp2b effect
in yeast, other features in the porin are necessary and not shared
by Omp2a (Figure S2 of Supporting information). B. melitensis
Omp2a was shown to form a pore that is more efficient in sugar
diffusion than Omp2b [25]. Whether the pore features are
Figure 2. Omp2b signal peptide is required for the Bax-suppressor effect and Omp2b is cleaved in yeast. A. Schematic representations
of the peptidic sequences of Omp2b variants. Predicted signal peptide (PSP) is represented by a white rectangle in Omp2b sequence. Amino acids
positions are indicated. Relative lengths of schematic sequences are on scale. B. Growth assay (drops of serial dilutions) on media allowing bax and
ORF expression repression or induction, for GL0007 (omp2a; negative control), GL0004 (omp2b; positive control), GL0013 (short-omp2b), and GL0011
(t-omp2b). Dilution factors are indicated. C. Upper part: summary of the growth assays under bax and ORF expression induction conditions; ‘‘++’’:
growth, ‘‘+’’: intermediate growth, ‘‘-’’: no growth. Lower part: Western blot detection of Omp2b variants, in total protein extracts from GL0002
(Omp2b), GL0010 (t-Omp2b) and GL0012 (short-Omp2b) cultured overnight under expression induction conditions. Tubulin detection: loading
control.
doi:10.1371/journal.pone.0013274.g002
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unknown. Characteristic porin structures are composed of beta-
barrels, with short periplasmic turns and external loops of variable
length [33]. Interestingly, the external L3 and L5 loops are
enriched in major structural differences between Omp2a and
Omp2b [25], as between PorB porins from Neisseria meningitidis and
gonorrheae, which have been characterized as showing opposite
effects regarding host apoptosis [26,27,28].
Among other hypotheses on Omp2b mechanism of action in
yeast, it would be tempting to speculate that the porin, once
processed, might associate with mitochondria in yeast, given (i)
the involvement of this organelle in Bax-induced lethality, (ii) the
mitochondrial localization of neisserial PorB in infected cells
[26,27,34], (iii) that ectopically produced bacterial b-barrels
lacking their SP have been shown to locate to yeast
mitochondria, by an import pathway shared with mitochondrial
beta-barrels, involving import receptors and the TOB/SAM
complex [35]. Alternatively, it is conceivable that Omp2b, in the
cytosol, might prevent Bax mitochondrial targeting, either
indirectly or by interacting with Bax directly. A pull-down
experiment to test if Bax and Omp2b physically interact in yeast
could not be performed since Omp2b is found in the insoluble
fraction of lyzed yeast cells, which is not surprising considering
its predicted tridimensional structure exposing hydrophobic side
chains [25]. Nevertheless, it is completely conceivable that
Omp2b prevents yeast cell death indirectly, that is without a
physical interaction with Bax, taking into account the pleiotropic
effects of Bax that have been proposed to be involved in yeast
cell death [11].
This study is based on a screening method involving a
functional assay in a "synthetic" system. Although several
proteins previously identified by this strategy have been
demonstrated to be involved in cell death inhibition in superior
eukaryotic systems [14,15,16,17,18], Omp2b and FecE should
be characterized further in a model that is more relevant to the
natural infection conditions, such as transfection of constructs
carrying these coding sequences in mammalian cells. Determin-
ing the role of Omp2b during infection should also rely on
a reverse genetics approach aiming at the comparison of wild
type and omp2b deletion strains of B. melitensis in their ability to
inhibit apoptosis of infected cells. However, this was recluded by
the essentiality of omp2b gene in B. melitensis (data not shown).
The observation that Omp2a production in yeast does not
induce a rescuing effect like Omp2b suggests that these
differences between Omp2a and Omp2b might be related not
only to porin functions but also to differences in apoptosis
modulation.
The possible effect of Omp2b inside infected cells might be
dependent on Omp2b delivery by outer membrane vesicles
(OMV) that have been shown to harbor Omp2b [36] and serve
as a secretion mechanism for effectors of other bacteria [37], or by
the release of outer membrane fragments. It was indeed reported
that Brucella LPS may travel to the host cell surface, supporting
trafficking involving outer membrane components in infected cells
[38,39].
To the best of our knowledge, this study illustrates the first
application of a screening strategy for the identification of Bax
inhibitors in yeast to a bacterial genome. The proteins identified
are anti-apoptotic effector candidates, of which the possible
modulator effect on apoptosis can be characterized in the future
in various mammalian cellular models of apoptosis.
Materials and Methods
Features and references for the yeast and bacterial strains used
in this study are available in Table 1. Primers sequences are
available in Table S1 of Supporting information section. The
construction and screening of the ‘‘bax+ORFeome’’ yeast library is
described in details in the Supporting information section.
Plasmids
pYES-DEST52-BMEI1305 (omp2b), pYES-DEST52-BMEI0660
(fecE), pYES-DEST52-BMEI1306 (omp2a), pYES-DEST52-
BMEI1249 (omp25) and pYES-DEST52-bclXL were obtained after
LR recombination reaction (Gateway, Invitrogen) between pYES-
DEST52 destination vector (Invitrogen 12286-019) and each
corresponding pDONR201-ORF from the B. melitensis 16M
ORFeome [23] or pDONR201-bclXL. pDONR201-bclXL was
obtained after a BP recombination reaction (Gateway, Invitrogen)
between pDONR201 and an amplification product of human
bclXL cDNA lacking the stop codon (from pcDNA3myc-bclXL,
kindly provided by T. Arnould, University of Namur, Belgium)
flanked by attB1 and attB2 recombination sites (primers attB1-bclXL
and attB2-bclXL). t-omp2b and short-omp2b were amplified from
pYES-DEST52-omp2b with t-omp2b-attB1 and t-omp2b-attB2 prim-
ers, and from pYES-DEST52-omp2b with FWDshortomp2b and t-
omp2b-attB2 primers, respectively. Each amplification product was
cloned in pDONR201 by BP reaction. Resulting entry vectors
were LR recombined with pYES-DEST52. Construction of
pYES-DEST52-long-omp2a was based on a 2-steps PCR strategy.
Fragment A was amplified from pYES-DEST52-omp2b with
primers long-omp2a_1 and long-omp2a_2. Fragment B was amplified
from pYES-DEST52-omp2a with primers long-omp2a_3 and long-
omp2a_4. long-omp2a was amplified by overlap extension PCR with
fragment A and B as matrixes, and with primers long-omp2a_1 and
Figure 3. The Bax-suppressor effect of Omp2b is not common
to B. melitensis outer membrane proteins. Drops of serial dilutions
of saturated cultures, on media allowing repression or induction of bax
and ORF expression, for GL0008 (omp25) and GL0007 (omp2a). GL0001
(bclXL) and GL0004 (omp2b) strains are positive controls for growth.
Dilution factors are indicated. Pictures were taken after 4 days of
growth at 30uC.
doi:10.1371/journal.pone.0013274.g003
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were cleaved by SpeI and Asp718I and then ligated to give pYES-
DEST52-long-omp2a.
Total protein extracts from S. cerevisiae
Extraction protocol was modified from [40] with 4% SDS in the
SDS sample buffer.
Antibodies used in Western blots
Bax was detected using HRP-coupled anti-Bax antibody (Santa
Cruz sc-493 HRP), diluted 1:100 in PBS-1% non-fat milk.
Phosphoglycerate kinase was detected using mouse monoclonal
anti-PGK antibody (Invitrogen Cat. No. A-6457), diluted 1:10,000
in PBS-1% non-fat milk. His6-tagged fusions were detected using
anti-6-His mouse monoclonal antibody (Covance Cat. No. MMS-
156R), diluted 1:1,000 in PBS-1% non-fat milk. Omp2b and
variants described in this study were detected using monoclonal
A6304D11G01 mouse antibody [25] as primary antibody.
Tubulin was detected using mouse monocolonal anti-alpha-
tubulin antibody (Sigma-Aldrich Cat. No. T5168) diluted
1:50,000 in PBS-1% non-fat milk. Anti-mouse IgG, HRP-linked
whole antibody (Amersham Cat. No. NA931, 1:5000 diluted in
PBS-1% non-fat milk) was always used as secondary antibody
except for Bax detection.
Supporting Information
Figure S1 Western blot showing that Omp2a or Omp25 is
produced in BF264-15Dau yeast clones transformed with
pYEp51-bax and pYES-DEST52-omp2a (GL0007) or pYES-
DEST52-omp25 (GL0008). Three clones were tested for each
strain. The detection was made with a monoclonal anti-His6 since
Omp2a and Omp25 coding sequences are fused with a His6 tag in
the pYES-DEST52 plasmids. The expected sizes of Omp2a and
Omp25 fused to His6 are 43.9 and 27.6 kDa, respectively. Bax was
detected with an anti-Bax antibody. The expected size of Bax is
21.2 kDa.
Found at: doi:10.1371/journal.pone.0013274.s001 (0.12 MB
PDF)
Figure S2 Replacing Omp2a signal peptide by Omp2b signal
peptide does not confer to Omp2a the ability to save yeast from
Bax-induced lethal effect. A fusion (long-omp2a) was constructed
by fusing the coding sequence corresponding to Omp2b predicted
signal peptide (PSP in main text) to the coding sequence
corresponding to mature Omp2a (i.e. Omp2a without its signal
peptide). (A) The expression of long-omp2a (GL0017) does not
allow growth on a medium inducing Bax production. The clones
expressing omp2b (GL0004) or omp2a (GL0007) are given as
positive and negative controls for growth on this medium,
respectively. (B) Western blot showing that long-Omp2a is
detectable in yeast (strain GL0018) using the A63-04D11-G01
monoclonal antibody.
Found at: doi:10.1371/journal.pone.0013274.s002 (0.40 MB
PDF)
Table S1 Primer sequences.
Found at: doi:10.1371/journal.pone.0013274.s003 (0.04 MB
PDF)
Text S1 Supporting information regarding the Bax-rescue
screening.
Found at: doi:10.1371/journal.pone.0013274.s004 (0.08 MB
PDF)
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